申请人:Barlaam Bernard
公开号:US20050101584A1
公开(公告)日:2005-05-12
The invention relates to novel compounds having the general formula: (I) and arc useful as selective ER-β ligands in the treatment or prophylaxis of Alzheimer's disease, anxiety disorders, depressive disorders, osteoporosis cardiovascular disease, rheumatoid arthritis or prostate cancer.
本发明涉及一种具有下列一般式的新化合物:(I),并且在治疗或预防阿尔茨海默病、焦虑症、抑郁症、骨质疏松、心血管疾病、类风湿性关节炎或前列腺癌中作为选择性ER-β配体具有用途。